Evidence map›Paper›PMID 39349469›Full record

ArticleNature communications2024

The co-occurrence of genetic variants in the TYR and OCA2 genes confers susceptibility to albinism.

David J Green, Vincent Michaud, Eulalie Lasseaux, Claudio Plaisant, UK Biobank Eye and Vision Consortium, Tomas Fitzgerald, Ewan Birney, Graeme C Black, Benoît Arveiler, Panagiotis I Sergouniotis

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Population- and haplotype-dependent variation aroundJID innovations : skin science from molecules to population health · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David J GreenDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Vincent MichaudDepartment of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France.ORCID 0000-0002-5788-392X
Eulalie LasseauxDepartment of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France.
Claudio PlaisantDepartment of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France.
UK Biobank Eye and Vision Consortium
Tomas FitzgeraldEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL- EBI), Wellcome Genome Campus, Cambridge, UK.ORCID 0000-0002-2370-8496
Ewan BirneyEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL- EBI), Wellcome Genome Campus, Cambridge, UK.ORCID 0000-0001-8314-8497
Graeme C Black *Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Benoît Arveiler *Department of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France.ORCID 0000-0002-2987-2932
Panagiotis I SergouniotisDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. panagiotis.sergouniotis@manchester.ac.uk.ORCID 0000-0003-0986-4123

Funding

NIHR Manchester Biomedical Research Centre 203308UK National Institute for Health Research (NIHR) Clinical Lecturer Programme CL-2017-06-001Wellcome TrustWellcome Trust 200990/Z/16/ZWellcome Trust (Wellcome) 224643/Z/21/Z
6 · The paper itself

Abstract

Although rare genetic conditions are mostly caused by DNA sequence alterations that functionally disrupt individual genes, large-scale studies using genome sequencing have started to unmask additional complexity. Understanding how combinations of variants in different genes shape human phenotypes is expected to provide important insights into the clinical and genetic heterogeneity of rare disorders. Here, we use albinism, an archetypal rare condition associated with hypopigmentation, as an exemplar for the study of genetic interactions. We analyse data from the Genomics England 100,000 Genomes Project alongside a cohort of 1120 individuals with albinism, and investigate the effect of dual heterozygosity for the combination of two established albinism-related variants: TYR:c.1205 G > A (p.Arg402Gln) [rs1126809] and OCA2:c.1327 G > A (p.Val443Ile) [rs74653330]. As each of these changes alone is insufficient to cause disease when present in the heterozygous state, we sought evidence of synergistic effects. We show that, when both variants are present, the probability of receiving a diagnosis of albinism is significantly increased (odds ratio 12.8; 95% confidence interval 6.0 - 24.7; p-value 2.1 ×10

Indexed as

AlbinismGenetic Predisposition to DiseaseMembrane Transport ProteinsMonophenol MonooxygenaseCohort StudiesFemaleGenetic VariationHeterozygoteHumansMalePhenotypePolymorphism, Single NucleotideMembrane Transport ProteinsMonophenol MonooxygenaseOCA2 protein, human

Identifiers

PMID39349469
PMCPMC11443028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.